Source:http://linkedlifedata.com/resource/pubmed/id/12365810
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5-6
|
pubmed:dateCreated |
2002-10-7
|
pubmed:abstractText |
Emergency vaccination is one of several measures which may be deployed to control outbreaks of foot-and-mouth disease. It can be a valuable adjunct to the application of the essential zoosanitary controls which must include rapid diagnosis, tracing, movement control and disinfection and which may also include slaughter of infected and in-contact animals and their safe disposal. Criteria which determine the successful application of emergency vaccination include access to vaccine(s) that (i) contain virus strain(s) of sufficient antigenic relatedness to the outbreak strain(s) (ii) are of the required type of vaccine formulation (iii) have acceptable innocuity and potency (iv) have appropriate availability, including quantity and immediacy of supply and (v) meet considerations of cost. Contingency planning should include provision for emergency vaccination and must address the complex decisions of not only when, where, and how to apply vaccine but also its economic consequences. Computer modelling may be a useful aid to cost benefit and decision support systems in this context. Planning must be detailed and regularly reviewed and should ensure, (i) that the legal and financial aspects are catered for (ii) that any contractual supply agreements are in place (iii) that information is collected and its currency maintained on the species, numbers and whereabouts of susceptible livestock (iv) that vaccination teams are formed and trained (v) that the vaccine cold chain is established and maintained (vi) that supplies of vaccination equipment are held in readiness and (vii) that briefing materials are available to inform the various stakeholders on relevant aspects of emergency vaccination. Knowledge concerning the characteristics and performance of emergency vaccines is summarised and areas identified for further research.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0147-9571
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
345-64
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:12365810-Animals,
pubmed-meshheading:12365810-Carrier State,
pubmed-meshheading:12365810-Cattle,
pubmed-meshheading:12365810-Cattle Diseases,
pubmed-meshheading:12365810-Disease Outbreaks,
pubmed-meshheading:12365810-Drug Storage,
pubmed-meshheading:12365810-Foot-and-Mouth Disease,
pubmed-meshheading:12365810-Sheep,
pubmed-meshheading:12365810-Sheep Diseases,
pubmed-meshheading:12365810-Swine,
pubmed-meshheading:12365810-Swine Diseases,
pubmed-meshheading:12365810-Vaccination,
pubmed-meshheading:12365810-Viral Vaccines
|
pubmed:year |
2002
|
pubmed:articleTitle |
Aspects of emergency vaccination against foot-and-mouth disease.
|
pubmed:affiliation |
Institute for Animal Health, Pirbright Laboratory, Surrey, UK.
|
pubmed:publicationType |
Journal Article,
Review
|